MaRS Innovation and the Ontario Centres of Excellence among the event's sponsors
On Tuesday, May 31, 2016, Diane Francis, the first woman editor of a national daily newspaper in Canada and a distinguished professor at the Ted Rogers School of Management, will guide a conversation that begins with a keynote address by Dr. Daniel Kraft, one of the world’s foremost health experts and innovators whose ideas and work are shaping digital health.
Dr. Daniel Kraft will be sharing his insights and experiences as ...
Montreal-based venture capital fund and entrepreneurship program brings over $20 million in funding and deep expertise in consumer electronics to MI members; first deal in speech recognition
TORONTO and MONTREAL, (May 3, 2016) — MaRS Innovation, the commercialization agent for fifteen of Toronto’s top academic institutions, and TandemLaunch, a Montreal-based venture capital fund and startup incubator that specializes in consumer electronics have formed a strategic partnership (see the Areas of Interest chart below for examples). The partnership will co-develop promising technology emerging ...
It’s been a busy quarter for UTEST company TrendMD. Fresh off their participation in Ycombinator’s Winter 2016 cohort, which was covered in TechCrunch, the company has announced partnerships with HighWire and Integra.
TrendMD, a Canadian start-up company, is a content recommendation engine for scholarly publishers. They work with over 2,000 medical journals by organizing and tailoring information to the appropriate audiences. This functionality creates several opportunities for various researchers to promote their research and clinical practices in their respective fields.
TrendMD launched through ...
Company initiating two new clinical trials for recurrent and newly diagnosed malignant gliomas
TORONTO and SAN DIEGO, (May 03, 2016) – Triphase Accelerator Corporation, a private drug development company dedicated to advancing novel compounds through Phase 2 proof-of-concept, today announced that it is expanding its current collaboration with Celgene Corp. in the development of marizomib for the potential treatment of malignant gliomas.
The two companies will collaborate on a Phase 2 study using marizomib (MRZ) as monotherapy in recurrent glioblastoma, as well as a Phase ...
"Closely-held Xagenic plans to conduct beta studies this year, in advance of a major chlamydia and gonorrhea clinical trial, with its rapid X1 molecular diagnostic testing system in preparation for market launches in Europe and the U.S.," Leonard Zahr wrote in a feature article on Xagenic's product development progress for BioTuesdays on April 19, 2016.
Xagenic was founded by University of Toronto Professor Shana Kelley in partnership with MaRS Innovation and U of T's Innovations & Partnerships Office in 2010. The company ...
Results for results in docetaxel-resistant prostate cancer models presented at the American Association for Cancer Research (AACR) Conference
TORONTO and SAN DIEGO (April 18, 2016) — Triphase Accelerator Corporation, a private drug development company dedicated to advancing novel compounds through Phase 2 proof-of-concept, and the Ontario Institute for Cancer Research (OICR), today announced positive results from a preclinical study of their CBZed-Nano™ (cabazitaxel cellulose nanoparticle) product in docetaxel-resistant prostate cancer mouse models. Preliminary results also showed that the nanoparticles accumulate in intracranial brain ...
Joel Liederman, vice-president of Physical Sciences, appeared on CanadaAM April 5, 2016 to talk about how to make a product. The interview is part of CanadaAM's "What's Next" segment on technology and entrepreneurship.
He and host Beverly Thomson discussed the process for moving from a napkin to a prototype to a market-ready product, including market testing, prototyping, soliciting more customer feedback, and eventually product launch.
"Marketing a product is a lot easier now than it used to be," said Liederman. "In the ...
TORONTO (March 17, 2016) — QD Solar, a Canadian technology company created by the University of Toronto (U of T) and MaRS Innovation, has received $2.55 million from the Sustainable Development Technology Canada (SDTC).
QD Solar’s funding — announced March 4, 2016 in Edmonton, Alberta by the Honourable Navdeep Bains, Minister of Innovation, Science and Economic Development — will galvanize a larger $8.7 million project to revolutionize conventional solar panels that waste a large portion of the available energy in sunlight because ...
Partnership expected to revolutionize the supply of transplantable lungs, with market launch in Europe by XENiOS® expected in 2017
HEILBRONN, Germany and TORONTO, Canada — XENiOS®, a commercial-stage medical device company, announced today it has invested $2.6 million in XOR-Labs Toronto (“XOR”), a spin-off of Toronto General Hospital at University Health Network (UHN), the world’s leading center for lung transplantation, created in partnership with MaRS Innovation.
This announcement was covered in FierceMedicalDevices and Cystic Fibrosis News Today.
VICE featured XOR's life-saving lung transplant technology ...